Bladder Cancer in 2010: How Far have We Come?
Bladder cancer is the fourth most common cancer and ranks eighth as a cause of death from cancer among men in the United States. Although guidelines assist in treatment, the art of managing bladder cancer, such as the decision to use neoadjuvant chemotherapy and the timing of cystectomy, is still va...
Gespeichert in:
| Veröffentlicht in: | CA: a cancer journal for clinicians 2010-07, Vol.60 (4), p.244-272 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 272 |
|---|---|
| container_issue | 4 |
| container_start_page | 244 |
| container_title | CA: a cancer journal for clinicians |
| container_volume | 60 |
| creator | Jacobs, Bruce L. Lee, Cheryl T. Montie, James E. |
| description | Bladder cancer is the fourth most common cancer and ranks eighth as a cause of death from cancer among men in the United States. Although guidelines assist in treatment, the art of managing bladder cancer, such as the decision to use neoadjuvant chemotherapy and the timing of cystectomy, is still variable. Bladder cancer has a propensity to recur, and with recurrence, a significant number of cases progress, which makes the early detection of high‐risk patients imperative. Advances in detection, surveillance, and treatment of bladder cancer are reviewed in this article. CA Cancer J Clin 2010. © 2010 American Cancer Society, Inc. |
| doi_str_mv | 10.3322/caac.20077 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_24P</sourceid><recordid>TN_cdi_proquest_miscellaneous_733648981</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2078270281</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3917-c5655eaf99ef590e76883344577daeaea813a7bc6a07b452df66f425af63052c3</originalsourceid><addsrcrecordid>eNp9kE1LAzEQhoMotlYv_gAJXgRhazbZJBsvUhdrhYIXxWNIs7O4ZT9q0rX035u61YMHmcPLDA8Pw4vQeUzGjFF6Y42xY0qIlAdoGPOERkkq2CEaknCLFGV8gE68X5LdLuUxGlDChRCSD1F0X5k8B4cz09gQZYMpicktnrUbPDUOv5tPwG-As7aGu1N0VJjKw9k-R-h1-vCSzaL58-NTNplHlqlYRpYLzsEUSkHBFQEp0pSxJOFS5gbCpDEzcmGFIXKRcJoXQhQJ5aYQjHBq2Qhd9d6Vaz868Gtdl95CVZkG2s5ryZhIUhU0I3T5h1y2nWvCc1oQSTlTTATouoesa713UOiVK2vjtjomeleh3lWovysM8MXe2C1qyH_Rn84CEPfApqxg-49KZ5NJ1ku_ACYIdnc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>607253936</pqid></control><display><type>article</type><title>Bladder Cancer in 2010: How Far have We Come?</title><source>Wiley Online Library Open Access</source><creator>Jacobs, Bruce L. ; Lee, Cheryl T. ; Montie, James E.</creator><creatorcontrib>Jacobs, Bruce L. ; Lee, Cheryl T. ; Montie, James E.</creatorcontrib><description>Bladder cancer is the fourth most common cancer and ranks eighth as a cause of death from cancer among men in the United States. Although guidelines assist in treatment, the art of managing bladder cancer, such as the decision to use neoadjuvant chemotherapy and the timing of cystectomy, is still variable. Bladder cancer has a propensity to recur, and with recurrence, a significant number of cases progress, which makes the early detection of high‐risk patients imperative. Advances in detection, surveillance, and treatment of bladder cancer are reviewed in this article. CA Cancer J Clin 2010. © 2010 American Cancer Society, Inc.</description><identifier>ISSN: 0007-9235</identifier><identifier>EISSN: 1542-4863</identifier><identifier>DOI: 10.3322/caac.20077</identifier><identifier>PMID: 20566675</identifier><identifier>CODEN: CAMCAM</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Antineoplastic Agents - therapeutic use ; Biomarkers, Tumor ; Bladder ; Cancer ; Cancer surgery ; Carcinoma - pathology ; Chemotherapy ; Cystectomy ; Cystoscopy ; Diagnostic Imaging ; Disease management ; Genetic Markers ; Humans ; Men ; Muscle, Smooth - pathology ; Muscle, Smooth - surgery ; Neoplasm Invasiveness ; Neoplasm Metastasis ; Neoplasm Recurrence, Local - prevention & control ; Neoplasm Staging ; Risk Factors ; Robotics ; Urinary Bladder Neoplasms - diagnosis ; Urinary Bladder Neoplasms - genetics ; Urinary Bladder Neoplasms - therapy ; Urinary Diversion</subject><ispartof>CA: a cancer journal for clinicians, 2010-07, Vol.60 (4), p.244-272</ispartof><rights>Copyright © 2010 American Cancer Society, Inc.</rights><rights>(c) 2010 American Cancer Society, Inc.</rights><rights>Copyright Lippincott Williams & Wilkins Jul/Aug 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3917-c5655eaf99ef590e76883344577daeaea813a7bc6a07b452df66f425af63052c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.3322%2Fcaac.20077$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.3322%2Fcaac.20077$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,11541,27901,27902,45550,45551,46027,46451</link.rule.ids><linktorsrc>$$Uhttps://onlinelibrary.wiley.com/doi/abs/10.3322%2Fcaac.20077$$EView_record_in_Wiley-Blackwell$$FView_record_in_$$GWiley-Blackwell</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20566675$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jacobs, Bruce L.</creatorcontrib><creatorcontrib>Lee, Cheryl T.</creatorcontrib><creatorcontrib>Montie, James E.</creatorcontrib><title>Bladder Cancer in 2010: How Far have We Come?</title><title>CA: a cancer journal for clinicians</title><addtitle>CA Cancer J Clin</addtitle><description>Bladder cancer is the fourth most common cancer and ranks eighth as a cause of death from cancer among men in the United States. Although guidelines assist in treatment, the art of managing bladder cancer, such as the decision to use neoadjuvant chemotherapy and the timing of cystectomy, is still variable. Bladder cancer has a propensity to recur, and with recurrence, a significant number of cases progress, which makes the early detection of high‐risk patients imperative. Advances in detection, surveillance, and treatment of bladder cancer are reviewed in this article. CA Cancer J Clin 2010. © 2010 American Cancer Society, Inc.</description><subject>Antineoplastic Agents - therapeutic use</subject><subject>Biomarkers, Tumor</subject><subject>Bladder</subject><subject>Cancer</subject><subject>Cancer surgery</subject><subject>Carcinoma - pathology</subject><subject>Chemotherapy</subject><subject>Cystectomy</subject><subject>Cystoscopy</subject><subject>Diagnostic Imaging</subject><subject>Disease management</subject><subject>Genetic Markers</subject><subject>Humans</subject><subject>Men</subject><subject>Muscle, Smooth - pathology</subject><subject>Muscle, Smooth - surgery</subject><subject>Neoplasm Invasiveness</subject><subject>Neoplasm Metastasis</subject><subject>Neoplasm Recurrence, Local - prevention & control</subject><subject>Neoplasm Staging</subject><subject>Risk Factors</subject><subject>Robotics</subject><subject>Urinary Bladder Neoplasms - diagnosis</subject><subject>Urinary Bladder Neoplasms - genetics</subject><subject>Urinary Bladder Neoplasms - therapy</subject><subject>Urinary Diversion</subject><issn>0007-9235</issn><issn>1542-4863</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kE1LAzEQhoMotlYv_gAJXgRhazbZJBsvUhdrhYIXxWNIs7O4ZT9q0rX035u61YMHmcPLDA8Pw4vQeUzGjFF6Y42xY0qIlAdoGPOERkkq2CEaknCLFGV8gE68X5LdLuUxGlDChRCSD1F0X5k8B4cz09gQZYMpicktnrUbPDUOv5tPwG-As7aGu1N0VJjKw9k-R-h1-vCSzaL58-NTNplHlqlYRpYLzsEUSkHBFQEp0pSxJOFS5gbCpDEzcmGFIXKRcJoXQhQJ5aYQjHBq2Qhd9d6Vaz868Gtdl95CVZkG2s5ryZhIUhU0I3T5h1y2nWvCc1oQSTlTTATouoesa713UOiVK2vjtjomeleh3lWovysM8MXe2C1qyH_Rn84CEPfApqxg-49KZ5NJ1ku_ACYIdnc</recordid><startdate>201007</startdate><enddate>201007</enddate><creator>Jacobs, Bruce L.</creator><creator>Lee, Cheryl T.</creator><creator>Montie, James E.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PADUT</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>201007</creationdate><title>Bladder Cancer in 2010: How Far have We Come?</title><author>Jacobs, Bruce L. ; Lee, Cheryl T. ; Montie, James E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3917-c5655eaf99ef590e76883344577daeaea813a7bc6a07b452df66f425af63052c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Antineoplastic Agents - therapeutic use</topic><topic>Biomarkers, Tumor</topic><topic>Bladder</topic><topic>Cancer</topic><topic>Cancer surgery</topic><topic>Carcinoma - pathology</topic><topic>Chemotherapy</topic><topic>Cystectomy</topic><topic>Cystoscopy</topic><topic>Diagnostic Imaging</topic><topic>Disease management</topic><topic>Genetic Markers</topic><topic>Humans</topic><topic>Men</topic><topic>Muscle, Smooth - pathology</topic><topic>Muscle, Smooth - surgery</topic><topic>Neoplasm Invasiveness</topic><topic>Neoplasm Metastasis</topic><topic>Neoplasm Recurrence, Local - prevention & control</topic><topic>Neoplasm Staging</topic><topic>Risk Factors</topic><topic>Robotics</topic><topic>Urinary Bladder Neoplasms - diagnosis</topic><topic>Urinary Bladder Neoplasms - genetics</topic><topic>Urinary Bladder Neoplasms - therapy</topic><topic>Urinary Diversion</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jacobs, Bruce L.</creatorcontrib><creatorcontrib>Lee, Cheryl T.</creatorcontrib><creatorcontrib>Montie, James E.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Research Library China</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>CA: a cancer journal for clinicians</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Jacobs, Bruce L.</au><au>Lee, Cheryl T.</au><au>Montie, James E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bladder Cancer in 2010: How Far have We Come?</atitle><jtitle>CA: a cancer journal for clinicians</jtitle><addtitle>CA Cancer J Clin</addtitle><date>2010-07</date><risdate>2010</risdate><volume>60</volume><issue>4</issue><spage>244</spage><epage>272</epage><pages>244-272</pages><issn>0007-9235</issn><eissn>1542-4863</eissn><coden>CAMCAM</coden><abstract>Bladder cancer is the fourth most common cancer and ranks eighth as a cause of death from cancer among men in the United States. Although guidelines assist in treatment, the art of managing bladder cancer, such as the decision to use neoadjuvant chemotherapy and the timing of cystectomy, is still variable. Bladder cancer has a propensity to recur, and with recurrence, a significant number of cases progress, which makes the early detection of high‐risk patients imperative. Advances in detection, surveillance, and treatment of bladder cancer are reviewed in this article. CA Cancer J Clin 2010. © 2010 American Cancer Society, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>20566675</pmid><doi>10.3322/caac.20077</doi><tpages>29</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | ISSN: 0007-9235 |
| ispartof | CA: a cancer journal for clinicians, 2010-07, Vol.60 (4), p.244-272 |
| issn | 0007-9235 1542-4863 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_733648981 |
| source | Wiley Online Library Open Access |
| subjects | Antineoplastic Agents - therapeutic use Biomarkers, Tumor Bladder Cancer Cancer surgery Carcinoma - pathology Chemotherapy Cystectomy Cystoscopy Diagnostic Imaging Disease management Genetic Markers Humans Men Muscle, Smooth - pathology Muscle, Smooth - surgery Neoplasm Invasiveness Neoplasm Metastasis Neoplasm Recurrence, Local - prevention & control Neoplasm Staging Risk Factors Robotics Urinary Bladder Neoplasms - diagnosis Urinary Bladder Neoplasms - genetics Urinary Bladder Neoplasms - therapy Urinary Diversion |
| title | Bladder Cancer in 2010: How Far have We Come? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T04%3A54%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_24P&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bladder%20Cancer%20in%202010:%20How%20Far%20have%20We%20Come?&rft.jtitle=CA:%20a%20cancer%20journal%20for%20clinicians&rft.au=Jacobs,%20Bruce%20L.&rft.date=2010-07&rft.volume=60&rft.issue=4&rft.spage=244&rft.epage=272&rft.pages=244-272&rft.issn=0007-9235&rft.eissn=1542-4863&rft.coden=CAMCAM&rft_id=info:doi/10.3322/caac.20077&rft_dat=%3Cproquest_24P%3E2078270281%3C/proquest_24P%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=607253936&rft_id=info:pmid/20566675&rfr_iscdi=true |